Assessment of 2 Different Techniques for Suppression of Respiratory Motion in Lung Cancer Treatment With Proton Therapy Using Magnetic Resonance Imaging (MRI)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03669341 |
|
Recruitment Status :
Completed
First Posted : September 13, 2018
Last Update Posted : June 9, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Healthy Volunteers | Other: Deep Inspiration Breath Hold (DIBH) Other: High Frequency Percussive Ventilation (HFPV) | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 20 participants |
| Allocation: | Non-Randomized |
| Intervention Model: | Sequential Assignment |
| Intervention Model Description: | All study participants will perform both techniques of suppression of respiratory motion at 4 weekly visits. They always start with the deep-inspiration-breath- hold (DIBH) technique, extended by prior hyperventilation while breathing 100% O2, followed by the high-frequency-percussive-ventilation (HFPV) technique. Inbetween the weekly visits, participants are requested to perform a daily, short breath-hold training at home. |
| Masking: | None (Open Label) |
| Primary Purpose: | Basic Science |
| Official Title: | Short-term Apnoea Training With Deep Inspiration Breath Hold vs High Frequency Percussive Ventilation for Apnoea-like Suppression of Respiratory Motion: a Pilot Study Using Magnetic Resonance Imaging at 1.5T Assessing Their Application for Proton Therapy Treatment of Lung Tumors |
| Actual Study Start Date : | October 10, 2018 |
| Actual Primary Completion Date : | March 11, 2019 |
| Actual Study Completion Date : | August 14, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Deep Inspiration Breath Hold (DIBH)
DIBH extended by prior hyperventilation while breathing 100% O2
|
Other: Deep Inspiration Breath Hold (DIBH)
human-based DIBH method with short-term breath-hold training |
|
Active Comparator: High Frequency Percussive Ventilation (HFPV)
passive Ventilation by a jet ventilator
|
Other: High Frequency Percussive Ventilation (HFPV)
device-based HFPV technique |
- Difference in MRI Images [ Time Frame: 3 weeks ]pulmonary anatomical structure points are evaluated by means of MRI scans. The difference of these MRI evaluations between the DIBH- and HFPV-technique is the primary outcome measure.
- Difference in breath-hold duration [ Time Frame: 3 weeks ]The difference between the DIBH- and HFPV-technique in breath-hold Duration is the secondary outcome measure
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 40 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- ability to give informed consent by signature
- healthy, i.e. normal physical and mental status
Exclusion Criteria:
- contraindications to MRI (non-MRI-suitable electronical & metal implants, claustrophobia)
- women who are pregnant or are breast feeding
- acute or chronic illness
- known or suspected non-compliance, drug or alcohol abuse
- inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant
- presence of any psychological or sociological condition potentially hampering compliance with the study protocol
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03669341
| Switzerland | |
| Paul Scherrer Institut, Center for Proton Therapy | |
| Villigen, Aargau, Switzerland, 5232 | |
| Principal Investigator: | Frank Emert, PhD | Paul Scherrer Institut, Center for Proton Therapy |
| Responsible Party: | Paul Scherrer Institut, Center for Proton Therapy |
| ClinicalTrials.gov Identifier: | NCT03669341 |
| Other Study ID Numbers: |
APNOPART_2018 |
| First Posted: | September 13, 2018 Key Record Dates |
| Last Update Posted: | June 9, 2021 |
| Last Verified: | June 2021 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
breath hold DIBH HFPV MRI |

